Divergent humoral responses to 23-valent pneumococcal polysaccharide vaccine in critically-ill burn and neurosurgical patients.

Critically ill hospitalized patients are at increased risk of infection so we assessed the immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPSV23) administered within six days of injury.This prospective observational study compared the immunogenicity of PPSV23 among critically ill b...

Full description

Bibliographic Details
Main Authors: Scott W Mueller, Laura J Baumgartner, Rob MacLaren, Robert Neumann, Arek J Wiktor, Tyree H Kiser, Gordon Lindberg, Luis Cava, Douglas N Fish, Edward N Janoff
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5951595?pdf=render